-
-
-
-
-
-
-
MannKind Provides Business Updates and 2026 Growth Drivers
-
-
-
-
-
-
-
MannKind to acquire scPharmaceuticals for up to $360 million
-
-
-
-
-
-
-
MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
-
-
-
-
-
-
-
MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results
-
-
-
-
-
-
-
Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device
-
-
-
-
-
-
-
MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc.
-
-
-
-
-
-
-
Pre-Open Stock Movers 01/17: (LPCN) (TA) (KNX) Higher; (SIG) (FUL) (MS) Lower (more...)
-
1,158,057 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

